
In Stock
Convergent Metabolic & Somatotropic Signaling
This stack is a focus for researchers studying the intersection of metabolic regulation and growth-hormone-axis activity. By combining Retatrutide and Tesamorelin within a single coordinated protocol, researchers examine how triple-agonist metabolic signaling interacts with GHRH-mediated somatotropic activity across preclinical models. Bacteriostatic water is included for reconstitution of the lyophilized components.
Retatrutide Triple Receptor Activation
The Retatrutide component is investigated for its simultaneous engagement of the GLP-1, GIP, and glucagon receptors. Researchers study how convergent activation of these three pathways influences energy expenditure, substrate utilization, and adipose signaling, examining the metabolic foundation of the combined stack.
Tesamorelin GHRH-Axis Modulation
The Tesamorelin component is investigated for its role as a growth-hormone-releasing hormone analog. Researchers study how GHRH-receptor engagement influences pulsatile growth hormone signaling and downstream metabolic effects, examining its contribution to body-composition and lipid-regulation research alongside the metabolic component of the stack.
For research use only.
testimonials
peptides
Our most popular peptides, in high-demand this year

verified coa's
The most powerful weight loss peptide studied, with clinical trials showing up to 24% body weight reduction in 48 weeks.
Trusted by 150+ Customers
